Lower-Risk Myelodysplastic Syndrome (MDS) Patients Exhibit Diminished Proteasome Proteolytic Activity and High Intracellular Reactive Oxygen Species (ROS) Levels - Zafeiropoulou, Kalliopi; Kalampounias, Georgios; Alexis, Spyridon; Androutsopoulou, Theodosia; Katsoris, Panagiotis; Symeonidis, Argiris (Curēus (Palo Alto, CA), 2023)
Keywords: Antibodies; Blood & organ donations; Bone marrow; Hematology; Inhibitor drugs; Oncology; Oxidative stress; Peptides; Proteins; Reactive oxygen species; Stem cells; Targeted cancer therapy; Therapeutics; United States--US; Texas; Massachusetts; Japan; Germany; ipss-r; ubiquitin-proteasome system; myelodysplastic syndromes; reactive oxygen species; proteasome inhibitors; bortezomib; cd34 positive; acute myeloid leukemia (aml); bone marrow; oxidative stress